- Home
- CGON vs RQI Comparison
CGON vs RQI Comparison
Compare CGON & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- RQI
- Stock Information
- Founded
- CGON 2010
- RQI 2002
- Country
- CGON United States
- RQI United States
- Employees
- CGON N/A
- RQI N/A
- Industry
- CGON
- RQI Trusts Except Educational Religious and Charitable
- Sector
- CGON
- RQI Finance
- Exchange
- CGON NYSE
- RQI Nasdaq
- Market Cap
- CGON 2.0B
- RQI 1.7B
- IPO Year
- CGON 2024
- RQI N/A
- Fundamental
- Price
- CGON $26.91
- RQI $12.44
- Analyst Decision
- CGON Strong Buy
- RQI
- Analyst Count
- CGON 11
- RQI 0
- Target Price
- CGON $63.30
- RQI N/A
- AVG Volume (30 Days)
- CGON 979.0K
- RQI 432.6K
- Earning Date
- CGON 08-07-2025
- RQI 01-01-0001
- Dividend Yield
- CGON N/A
- RQI 8.20%
- EPS Growth
- CGON N/A
- RQI N/A
- EPS
- CGON N/A
- RQI N/A
- Revenue
- CGON $662,000.00
- RQI N/A
- Revenue This Year
- CGON N/A
- RQI N/A
- Revenue Next Year
- CGON $21,843.29
- RQI N/A
- P/E Ratio
- CGON N/A
- RQI N/A
- Revenue Growth
- CGON 224.51
- RQI N/A
- 52 Week Low
- CGON $14.80
- RQI $9.17
- 52 Week High
- CGON $40.47
- RQI $12.64
- Technical
- Relative Strength Index (RSI)
- CGON 54.12
- RQI 49.27
- Support Level
- CGON $25.14
- RQI $12.32
- Resistance Level
- CGON $27.09
- RQI $12.71
- Average True Range (ATR)
- CGON 1.50
- RQI 0.15
- MACD
- CGON -0.04
- RQI 0.00
- Stochastic Oscillator
- CGON 53.56
- RQI 41.30
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.